PRSS35 and liver cancer: Overexpression of PRSS35 in PLC, HepG2, and Hep3B liver cancer cells further led to the identification of a short form (SF-PRSS35) in the culture medium (Supplementary Fig. 1b), suggesting that this short form was specifically secreted.